Empire Financial Management Company, LLC Gilead Sciences, Inc. Transaction History
Empire Financial Management Company, LLC
- $347 Billion
- Q2 2025
A detailed history of Empire Financial Management Company, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Empire Financial Management Company, LLC holds 2,600 shares of GILD stock, worth $306,410. This represents 0.08% of its overall portfolio holdings.
Number of Shares
2,600
Previous 2,600
-0.0%
Holding current value
$306,410
Previous $291 Million
1.05%
% of portfolio
0.08%
Previous 0.09%
Shares
4 transactions
Others Institutions Holding GILD
# of Institutions
2,326Shares Held
1.02BCall Options Held
12.1MPut Options Held
9.13M-
Black Rock Inc. New York, NY121MShares$14.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.1 Billion0.22% of portfolio
-
State Street Corp Boston, MA59.2MShares$6.98 Billion0.25% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$5.46 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA37.5MShares$4.42 Billion0.79% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $148B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...